morphiceptin, n-me-phe(3)- has been researched along with tyrosyl-prolyl-leucyl-glycinamide in 1 studies
Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (tyrosyl-prolyl-leucyl-glycinamide) | Trials (tyrosyl-prolyl-leucyl-glycinamide) | Recent Studies (post-2010) (tyrosyl-prolyl-leucyl-glycinamide) |
---|---|---|---|---|---|
95 | 1 | 1 | 109 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, LJ; Hackler, L; Kastin, AJ; Zadina, JE | 1 |
1 other study(ies) available for morphiceptin, n-me-phe(3)- and tyrosyl-prolyl-leucyl-glycinamide
Article | Year |
---|---|
Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Topics: Amino Acid Sequence; Animals; Brain; Cerebellum; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Guinea Pigs; Molecular Sequence Data; MSH Release-Inhibiting Hormone; Peptide Fragments; Peptides, Cyclic; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Synaptic Membranes | 1994 |